Professor Joy Ho leads a panel of Asia-Pacific-based experts, exchanging their practical experiences of identifying appropriate patients for CAR T-cell therapy, aspects of pre- and post-infusion management, and treatment sequencing, and sharing insights into optimizing outcomes in R/R DLBCL or R/R FL.
This educational activity is intended for an audience of non-US, non-UK and on-label Asia Pacific healthcare professionals.
Watch it live: Tuesday 29th July, 09:00-10:30 (CEST)